Compare TRVI & BLBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TRVI | BLBD |
|---|---|---|
| Founded | 2011 | 1927 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Construction/Ag Equipment/Trucks |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.3B |
| IPO Year | 2019 | 2013 |
| Metric | TRVI | BLBD |
|---|---|---|
| Price | $17.14 | $77.36 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 11 | 6 |
| Target Price | $21.55 | ★ $68.00 |
| AVG Volume (30 Days) | ★ 3.0M | 445.2K |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 31.91 | 22.78 |
| EPS | N/A | ★ 1.84 |
| Revenue | N/A | ★ $1,480,099,000.00 |
| Revenue This Year | N/A | $5.87 |
| Revenue Next Year | N/A | $6.83 |
| P/E Ratio | ★ N/A | $42.13 |
| Revenue Growth | N/A | ★ 9.87 |
| 52 Week Low | $6.55 | $42.95 |
| 52 Week High | $20.22 | $83.39 |
| Indicator | TRVI | BLBD |
|---|---|---|
| Relative Strength Index (RSI) | 49.62 | 59.23 |
| Support Level | $16.24 | $74.58 |
| Resistance Level | $20.15 | $81.07 |
| Average True Range (ATR) | 1.37 | 2.79 |
| MACD | -0.23 | -0.04 |
| Stochastic Oscillator | 22.61 | 58.98 |
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, non-IPF interstitial lung disease, or non-IPF ILD, and refractory chronic cough, or RCC. Haduvio is an oral extended-release formulation of nalbuphine. The Company operates and manages its business as one reportable segment. Such a segment is the business of developing and commercializing the investigational therapy Haduvio.
Blue Bird Corp is an American bus manufacturing company. It is an independent designer and manufacturer of school buses. The company operates in two segments; the Bus segment which involves the design, engineering, manufacture, and sales of school buses and extended warranties; and the Parts segment which includes the sales of replacement bus parts. Geographically, the company generates a majority of its revenue from its customers in the United States and the rest from Canada and Rest of the world.